Papillary thyroid carcinoma in Mexican patients: Clinical aspects and prognostic factors

被引:30
作者
Herrera, MF
LopezGraniel, CM
Saldana, J
GamboaDominguez, A
RichaudPatin, Y
VargasVorackova, F
AngelesAngeles, A
Llorente, L
Castillo, C
Perez, B
Rivera, R
Gonzalez, O
Rull, J
机构
[1] INST NACL NUTR SALVADOR ZUBIRAN,DEPT ENDOCRINOL,MEXICO CITY 14000,DF,MEXICO
[2] INST NACL NUTR SALVADOR ZUBIRAN,DEPT NUCL MED,MEXICO CITY 14000,DF,MEXICO
[3] INST NACL NUTR SALVADOR ZUBIRAN,CLIN THYROID,MEXICO CITY 14000,DF,MEXICO
[4] INST NACL NUTR SALVADOR ZUBIRAN,DEPT PATHOL,MEXICO CITY 14000,DF,MEXICO
[5] INST NACL NUTR SALVADOR ZUBIRAN,DEPT IMMUNOL,MEXICO CITY 14000,DF,MEXICO
[6] INST NACL NUTR SALVADOR ZUBIRAN,DEPT GASTROENTEROL,MEXICO CITY 14000,DF,MEXICO
[7] INST NACL NUTR SALVADOR ZUBIRAN,DEPT SOCIAL WORK,MEXICO CITY 14000,DF,MEXICO
关键词
D O I
10.1007/s002689900017
中图分类号
R61 [外科手术学];
学科分类号
摘要
The present study characterizes papillary thyroid carcinoma (PTC) in a Mexican patient sample and evaluates potential prognostic factors for recurrence. Clinical records of 229 patients with PTC were analyzed. Surgical specimens were rereviewed and DNA ploidy determined. Cox logistic regression was used to explore prognostic factors. Mean age +/- SD of the patients was 42 +/- 16 years, with a male/female ratio of 24:205. A thyroid mass was the initial manifestation in 99%. Extrathyroid invasion occurred in 45% and nodal metastases in 38%. Mean size +/- SD of the tumors was 3 +/- 2 cm. By flow cytometry 88% of the tumors were DNA euploid and 12% aneuploid. Complete tumor resection was achieved in 83% with an operative mortality of 0.4%. Postoperative hormone suppression was administered in 65% and remnant I-131 thyroid ablation in 84%. The 10-year recurrence-free survival was 85%. In the group of patients with tumors totally removed and without distant metastases, none of the 14 evaluated variables demonstrated statistical significance as an independent prognostic factor for recurrence. However, the group of patients in whom a combination of the following factors was present-age greater than or equal to 40 years, tumor size greater than or equal to 3 cm, local invasion, and lymph node metastases-showed a higher incidence of tumor recurrence.
引用
收藏
页码:94 / 100
页数:7
相关论文
共 40 条
[1]
[Anonymous], SURG PATHOLOGY THYRO
[2]
BACKDAHL M, 1986, WORLD J SURG, V10, P974
[3]
MULTIFACTORIAL STUDY OF PROGNOSTIC FACTORS IN DIFFERENTIATED THYROID-CARCINOMA AND A REEVALUATION OF THE IMPORTANCE OF AGE [J].
BACOURT, F ;
ASSELAIN, B ;
SAVOIE, JC ;
DHUBERT, E ;
MASSIN, JP ;
DOUCET, G ;
LEGER, A ;
GARNIER, H .
BRITISH JOURNAL OF SURGERY, 1986, 73 (04) :274-277
[4]
CHANGING CLINICAL, PATHOLOGIC, THERAPEUTIC, AND SURVIVAL PATTERNS IN DIFFERENTIATED THYROID-CARCINOMA [J].
CADY, B ;
SEDGWICK, CE ;
MEISSNER, WA ;
BOOKWALTER, JR ;
ROMAGOSA, V ;
WERBER, J .
ANNALS OF SURGERY, 1976, 184 (05) :541-553
[5]
CADY B, 1979, CANCER, V43, P810, DOI 10.1002/1097-0142(197903)43:3<810::AID-CNCR2820430306>3.0.CO
[6]
2-B
[7]
CADY B, 1988, SURGERY, V104, P947
[8]
CARCANGIU ML, 1985, CANCER, V55, P805, DOI 10.1002/1097-0142(19850215)55:4<805::AID-CNCR2820550419>3.0.CO
[9]
2-Z
[10]
COX DR, 1972, J R STAT SOC B, V34, P187